DeepMed Research

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.eortc.be

Clinical Trials

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

Completed

Conditions: Colorectal Cancer
Prostate Cancer
Breast Cancer
Gastric Cancer
Ovarian Cancer
Lung Cancer
Pancreatic Cancer
Thromboembolism

First Posted Date: 2007-02-12

Last Posted Date: 2013-06-12

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 64

Registration Number: NCT00433602

Locations: 🇳🇱
Slotervaart Ziekenhuis, Amsterdam, Netherlands

Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: lapatinib ditosylate
Drug: tamoxifen citrate
Other: pharmacological study

First Posted Date: 2007-01-18

Last Posted Date: 2024-03-08

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 20

Registration Number: NCT00424164

Locations: 🇫🇷
Centre Regional Rene Gauducheau, Dijon, France

Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2007-01-18

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 38

Registration Number: NCT00424060

Locations: 🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

Phase 2

Conditions: Ovarian Cancer
Sarcoma
Small Intestine Cancer

First Posted Date: 2006-12-13

Last Posted Date: 2014-08-08

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 118

Registration Number: NCT00410462

Locations: 🇳🇱
Leiden University Medical Center, Leiden, Netherlands

Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery

Phase 2

Terminated

Conditions: Lung Cancer

First Posted Date: 2006-10-19

Last Posted Date: 2012-07-18

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 13

Registration Number: NCT00389688

Locations: 🇧🇪
Universitair Ziekenhuis Antwerpen, Edegem, Belgium

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

Phase 3

Active, not recruiting

Conditions: Lymphoma

First Posted Date: 2006-09-21

Last Posted Date: 2024-02-22

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 1158

Registration Number: NCT00379041

Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer

Phase 3

Completed

Conditions: Fallopian Tube Cancer
Ovarian Cancer
Primary Peritoneal Cavity Cancer

First Posted Date: 2005-12-09

Last Posted Date: 2013-08-27

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 835

Registration Number: NCT00263822

Locations: 🇫🇷
Centre Leon Berard, Lyon, France
🇫🇷
Clinique Victor Hugo, Le Mans, France
🇮🇹
Ospedale Santa Maria Goretti, Latina, Italy

and more 89 locations

Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Phase 2

Completed

Conditions: Malignant Mesothelioma

First Posted Date: 2005-09-28

Last Posted Date: 2012-07-18

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 59

Registration Number: NCT00227630

Locations: 🇧🇪
Universitair Ziekenhuis Antwerpen, Edegem, Belgium
🇳🇱
Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam, Netherlands
🇳🇱
Sint Antonius Ziekenhuis, Nieuwegein, Netherlands

and more 5 locations

Radiation Therapy or Temozolomide in Treating Patients With Gliomas

Phase 3

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Radiation: radiation therapy
Drug: temozolomide

First Posted Date: 2005-09-16

Last Posted Date: 2016-10-12

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 709

Registration Number: NCT00182819

Locations: 🇨🇦
Edmond Odette Cancer Centre at Sunnybrook, Toronto, Ontario, Canada
🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
🇨🇦
Allan Blair Cancer Centre at Pasqua Hospital, Regina, Saskatchewan, Canada

and more 86 locations

Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2005-08-10

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 20

Registration Number: NCT00128700

Locations: 🇳🇱
Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam, Netherlands
🇩🇪
Klinikum der Universitaet Regensburg, Regensburg, Germany
🇧🇪
U.Z. Gasthuisberg, Leuven, Belgium

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy